Rhinitis medicamentosa.
Rhinitis medicamentosa, the syndrome of rebound nasal congestion secondary to prolonged topical intranasal use of vasoconstrictors, is reviewed. In this condition, the nasal airway is very obstructed; atrophic rhinitis is the most serious complication. Management consists of withdrawing the offending nasal spray and alleviating the nasal obstruction by means of any of several treatment modalities.
D006801:Humans; D014663:Nasal Decongestants / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D009666:Nose / Q000502:physiology; D012223:Rhinitis, Vasomotor / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy
D014663:Nasal Decongestants